Table 3.

Clinical characteristics of the fastsing blood samples of the study subjects before the control period (Pre), after the control/before exercise (Mid) and after the exercise period (Post).

Variable	Pre (n = 17) mean ±SD	Mid (n = 17) mean ±SD	Post (n = 17 SD) mean ±SD
Glucose (mmol/L)	5.25 ± 0.30	5.15 ± 0.30	5.35 ± 0.31**
HDL (mmol/L)	1.30 ± 0.34	1.38 ± 0.34	1.13 ± 0.28**
LDL (mmol/L)	2.60 ± 0.59	2.72 ± 0.60	2.50 ± 0.56**
FFA (mmol/L)	699.29 ± 355.75	403.88 ± 195.87##	427.24 ± 127.94
Trigly (mmol/L)	0.95 ± 0.41	1.13 ± 0.65#	1.10 ± 0.51
Insulin (IU/L)	54.94 ± 28.82	77.80 ± 33.99##	77.32 ± 40.95
HOMA-IR	12.9 ± 6.8	18.1 ± 8.3	18.7 ± 10.6

FFA, free fatty acids; Trigly, triglycerides; HOMA-IR, homeostatic model assessment of insulin resistance (

^#p < 0.05,

^##p < 0.01, ^###p < 0.001) from the baseline (Pre); Statistically significant change (

^**p < 0.01) from the post-control period (Mid).